Genentech, 1 DNA Way, South San Francisco, CA, 94080, USA.
Eli Lilly, Indianapolis, IN, USA.
Ther Innov Regul Sci. 2020 Nov;54(6):1269-1274. doi: 10.1007/s43441-020-00143-1. Epub 2020 Mar 14.
An opportunity exists to leverage the collective insights and experiences of phactMI™ member companies on current medical information (MI) services across the pharmaceutical industry. The collective insights provide considerations for refined MI strategies and enhanced MI services. The trend of organizational structure and challenge of resourcing for MI services are key areas to support efficiency and bring value to the overall organization.
Between December 2017 and February 2018, all 27 phactMI™ member companies were electronically sent a 300-question survey to support the development of MI services across the pharmaceutical industry. The survey had 9 key areas of focus, including organizational structure and resourcing.
All 27 companies responded to the survey. Although the 27 companies survey differed in structure and size, the MI responsibilities performed both by in-house and outsourced groups were similar with each organization. Half of the groups outsourced various responsibilities which supported the non-product roles, such as quality assurance, compliance reporting, vendor operations management, reporting/analytics, technology and digital support, content-related process work, presentation specialists, and payer and health system support. Despite the ever-changing nature of the pharmaceutical industry, most responsibilities and outsourced work by MI groups remain the same over time.
These findings provide MI teams various options for organizational structuring and resource strategies for MI services. These results highlight the services and focus areas that MI departments can explore and support the development of additional MI services across the pharmaceutical industry.
有机会利用 phactMI™ 成员公司在整个制药行业当前医疗信息 (MI) 服务方面的集体洞察力和经验。这些集体见解为完善 MI 策略和增强 MI 服务提供了考虑因素。MI 服务的组织结构趋势和资源配置挑战是支持效率并为整个组织带来价值的关键领域。
在 2017 年 12 月至 2018 年 2 月期间,向所有 27 家 phactMI™ 成员公司发送了一份 300 个问题的电子调查,以支持整个制药行业的 MI 服务发展。该调查有 9 个重点关注领域,包括组织结构和资源配置。
所有 27 家公司都对调查做出了回应。尽管 27 家公司的调查结构和规模不同,但内部和外包团体执行的 MI 职责在每个组织中都相似。一半的团体将各种职责外包出去,以支持非产品角色,如质量保证、合规报告、供应商运营管理、报告/分析、技术和数字支持、内容相关流程工作、演示专家以及支付方和医疗系统支持。尽管制药行业的性质不断变化,但 MI 团队的大多数职责和外包工作随着时间的推移保持不变。
这些发现为 MI 团队提供了各种组织结构和 MI 服务资源策略的选择。这些结果突出了 MI 部门可以探索和支持整个制药行业更多 MI 服务发展的服务和重点领域。